Evidence-based cardiology

Evidence-based cardiology

by Cannon, Christopher P.

Type Book
Rate 0.0 /5

Thoroughly updated for its Third Edition, this pocket-sized handbook provides easy access to clinical trial data that are crucial in therapeutic decision-making. The book enables clinicians to quickly review the studies that support or refute an intervention and choose the most appropriate, cost-effective treatment. Each chapter summarizes the pathophysiology of a disease and guideline-recommended diagnostic tests and treatments, and presents synopses of the major clinical trials for all therap…

Read More ↓

Title Statements

  • Full title :Evidence-based cardiology / Christopher P. Cannon, Benjamin A. Steinberg.

Summary

Thoroughly updated for its Third Edition, this pocket-sized handbook provides easy access to clinical trial data that are crucial in therapeutic decision-making. The book enables clinicians to quickly review the studies that support or refute an intervention and choose the most appropriate, cost-effective treatment. Each chapter summarizes the pathophysiology of a disease and guideline-recommended diagnostic tests and treatments, and presents synopses of the major clinical trials for all therapies. New sections in this Third Edition cover peripheral artery disease and drug-eluting stents. This.

Read More ↓

Edition Statements

  • Publication Date:2011
  • Edition:3rd ed

Publication Statements

Notes

Revised edition of: Evidence-based cardiology / Peter J. Sharis, Christopher P. Cannon. c2003.

The Physical Object

  • Description:1 online resource (xv, 480 pages) : : illustrations

Edition Identifiers

  • ISBN:9781469876542, 146987654X, 1451124643, 9781451124644
  • oclc:ocn690106783
  • LC Classification:RC669.15
  • Dewey Decimal:616.1/2

Table of Contents

EVIDENCE-BASED CARDIOLOGY; CONTENTS; PREFACE; CONTRIBUTORS; 1. Preventive Cardiology: Risk Factors for Coronary Artery Disease and Primary and Secondary Prevention Trials; CHOLESTEROL, LIPIDS, AND DIET; Epidemiology; National Cholesterol Education Program Guidelines; DIET AND VITAMINS; Special Diets; DRUGS; Bile Resins (e.g., Cholestyramine, Colestipol); Fibric Acid Derivatives (e.g., Gemfibrozil, Fenofibrate); Cholesterol Absorption Inhibitors; 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors (Statins); PRIMARY PREVENTION TRIALS; SECONDARY PREVENTION TRIALS.

COMBINED PRIMARY AND SECONDARY PREVENTION TRIALSEARLY STATIN INITIATION TRIALS; Raising HDL Cholesterol; NIACIN; SMOKING; DIABETES; Metabolic Syndrome; HYPERTENSION; Epidemiology; Etiology; Diagnosis, Joint National Committee 7 Classification; Treatment; NONPHARMACOLOGIC; PHARMACOLOGIC; Target Blood Pressure; OBESITY; SEDENTARY LIFESTYLE AND EXERCISE; NONMODIFIABLE RISK FACTORS; Family History; Age; Gender; ALCOHOL; HORMONAL STATUS AND HORMONAL THERAPY; C-REACTIVE PROTEIN; OTHER POTENTIAL RISK FACTORS; Homocysteine; Lipoprotein-associated Phospholipase A2; Infection; Genetic Markers.

ANTIPLATELET DRUGS FOR PRIMARY…

Read More ↓

Subjects

Writers

More from this Series

Rate & Review

0.0/5
(0 people Voted)

No reviews yet. Be the first to rate this work.

Files & Downloads

  • Evidence-Based Cardiology -- (.pdf)

    PDF · 2.8 MB · updated